62 results
F-4
EX-25.1
TAK
Takeda Pharmaceutical Co
9 Aug 19
Registration of securities (foreign)
6:27am
UNION BANK, N.A.
(Exact name of Trustee as specified in its charter)
94-0304228
I.R.S. Employer Identification No.
1251 Avenue of the Americas …
New York, New York
(Address of principal executive offices)
(Zip Code)
General Counsel
MUFG Union Bank, N.A.
1251 Avenue of the Americas
New York
6-K
TAK
Takeda Pharmaceutical Co
8 Dec 22
Current report (foreign)
6:46am
Number
Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
SIGNATURES
Pursuant to the requirements … Controller
News Release
Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
The European Commission
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
18 Oct 23
Current report (foreign)
6:20am
results of the study will be presented at a future medical meeting or published in a peer-reviewed journal. Alofisel is approved in the European Union … It is the first allogeneic stem cell therapy to receive centralized marketing authorization approval in the European Union, and the first expanded human
20FR12B
EX-10.12
TAK
Takeda Pharmaceutical Co
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
Exhibit 10.12
TAKEDA PHARMACEUTICAL COMPANY LIMITED
The Company
MUFG UNION BANK, N.A.
Trustee
INDENTURE
Dated as of November 26, 2018 … Pharmaceutical Company Limited, a joint-stock corporation (kabushiki kaisha) organized under the laws of Japan (the “Company”), and MUFG Union Bank, N.A
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
19 Apr 24
Current report (foreign)
6:12am
by market).1,2 Vedolizumab SC has been granted marketing authorization in the United States, European Union and more than 50 countries. Vedolizumab IV has … been granted marketing authorization in more than 70 countries, including the United States and European Union. Globally, vedolizumab IV and SC have
6-K
koz 5c5ylzhkaf
28 Sep 23
Current report (foreign)
6:17am
20FR12B/A
EX-10.12
8xwvkyucy
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
F-4
EX-5.1
3i3urgg2ei4lpu4 tqgf
9 Aug 19
Registration of securities (foreign)
6:27am
F-4
EX-5.2
8gdvk8c07g4
9 Aug 19
Registration of securities (foreign)
6:27am
20FR12B
EX-10.7
my4 nxt3p2c12f3
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B/A
EX-10.7
s9th574oujg784xj
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
DRS/A
EX-10.7
y84kp
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
EX-10.14
km9f2itqqaeg
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B/A
EX-10.14
af22bne5ophmhpwe
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
DRS/A
EX-10.9
6w8q4
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B
EX-10.9
he61sah73rma4k6vqhkj
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
20FR12B/A
EX-10.9
k4myqtipe6jgbfb
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
EX-10.5
qdblrwja y8siwp
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
EX-10.5
07arp mw3
16 Nov 18
Draft registration statement (amended)
12:00am
20FR12B/A
EX-10.5
7h629nxlw2tccf5q
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am